Metagenomi Inc (NASDAQ: MGX) on Tuesday, soared 8.45% from the previous trading day, before settling in for the closing price of $1.42. Within the past 52 weeks, MGX’s price has moved between $1.23 and $5.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -3.60%. With a float of $21.80 million, this company’s outstanding shares have now reached $37.38 million.
In an organization with 202 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -193.73%, and the pretax margin is -184.18%.
Metagenomi Inc (MGX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Metagenomi Inc is 41.67%, while institutional ownership is 24.90%. The most recent insider transaction that took place on Jun 06 ’25, was worth 348. In this transaction an insider of this company sold 199 shares at a rate of $1.75, taking the stock ownership to the 16,693 shares. Before that another transaction happened on Jun 06 ’25, when Company’s Chief Medical Officer sold 5,239 for $1.75, making the entire transaction worth $9,168. This insider now owns 109,135 shares in total.
Metagenomi Inc (MGX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.60% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Metagenomi Inc (MGX) is currently performing well based on its current performance indicators. A quick ratio of 5.85 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.08 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.47 million. That was inferior than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.26%.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 18.02%, which indicates a significant decrease from 35.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.30% in the past 14 days, which was lower than the 78.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5994, while its 200-day Moving Average is $2.1697. However, in the short run, Metagenomi Inc’s stock first resistance to watch stands at $1.5963. Second resistance stands at $1.6527. The third major resistance level sits at $1.7458. If the price goes on to break the first support level at $1.4468, it is likely to go to the next support level at $1.3537. Assuming the price breaks the second support level, the third support level stands at $1.2973.
Metagenomi Inc (NASDAQ: MGX) Key Stats
Market capitalization of the company is 57.57 million based on 37,381K outstanding shares. Right now, sales total 52,300 K and income totals -78,060 K. The company made 4,130 K in profit during its latest quarter, and -25,040 K in sales during its previous quarter.
